Telehealth Expansion Medaica is actively expanding its telehealth and remote diagnostics platform, with a recent launch of Telehealth+ and a M1 Telehealth Stethoscope. This presents opportunities to partner with hospitals and health systems seeking to scale remote patient monitoring and virtual exams.

Rural Access Focus The M1 stethoscope program includes free devices for qualifying rural or underserved patients, highlighting a strategic emphasis on improving access in underserved markets. This creates openings for partnerships with payer programs, community clinics, and government initiatives targeting rural health.

Integrated Platform Medaica combines at home self-exams with virtual HCP exams on a FDA-cleared platform, supported by AI and low-cost sensors. This strengths alignment with health systems seeking end-to-end digital diagnostics, enabling upsell of platform licenses, remote monitoring services, and analytics contracts.

Mid-market Growth With revenue in the low-millions and a lean team, Medaica is positioned for rapid growth through channel sales, partnerships with telehealth providers, and hospital networks looking to differentiate with digital heart and lung screening solutions.

Global Footprint Headquartered in the US with offices in Europe, Medaica targets cross-border deployments and international pilots. This offers opportunity to collaborate on multi-country contracts, regulatory navigation support, and regional implementation services.